Mostrar el registro sencillo del ítem

dc.contributor.authorM., Majem
dc.contributor.authorO., Juan
dc.contributor.authorA., Insa
dc.contributor.authorN., Reguart
dc.contributor.authorJ.M., Trigo
dc.contributor.authorE., Carcereny
dc.contributor.authorGarcía Campelo, María del Rosario 
dc.contributor.authorY., Garcia
dc.contributor.authorM., Guirado
dc.contributor.authorM., Provencio
dc.date.accessioned2022-02-01T12:59:52Z
dc.date.available2022-02-01T12:59:52Z
dc.date.issued2019
dc.identifier.issn1699-048X
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/30446985es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16054
dc.description.abstractNon-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper molecular knowledge; so, more options can be offered to patients with driver mutations. Groups with specific treatments account for around 25% and demonstrate significant increases in overall survival, and in some subgroups, it is important to evaluate each treatment alternative in accordance with scientific evidence, and even more so with immunotherapy. New treatments similarly mean that we must reconsider what should be done in oligometastatic disease where local treatment attains greater value.en
dc.language.isoenges
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshImmunotherapy*
dc.subject.meshClinical Trials as Topic*
dc.subject.meshLung Neoplasms*
dc.subject.meshCarcinoma*
dc.subject.meshRadiotherapy*
dc.subject.meshHumans*
dc.subject.meshCombined Modality Therapy*
dc.subject.meshPractice Guidelines as Topic*
dc.subject.meshPrognosis*
dc.titleSEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)en
dc.typeArtigoes
dc.identifier.doi10.1007/s12094-018-1978-1
dc.identifier.pmid30446985
dc.identifier.sophos34017
dc.issue.number1es
dc.journal.titleClinical & Translational Oncologyes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Oncoloxía médicaes
dc.page.initialWed Mar 01 00:00:00 CET 2017es
dc.rights.accessRightsopenAccesses
dc.subject.decscarcinoma*
dc.subject.decspronóstico*
dc.subject.decstratamiento combinado*
dc.subject.decsinmunoterapia*
dc.subject.decsensayos clínicos como asunto*
dc.subject.decsradioterapia*
dc.subject.decshumanos*
dc.subject.decsguías de práctica clínica como asunto*
dc.subject.decsneoplasias pulmonares*
dc.subject.keywordCHUACes
dc.typefidesGuías Clínicases
dc.typesophosGuías Clínicases
dc.volume.number21es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional